Literature DB >> 3502811

Lithium toxicity and mefenamic acid. A possible interaction and the role of prostaglandin inhibition.

R K Shelley1.   

Abstract

An elderly patient with bipolar manic-depressive psychosis, stabilised satisfactorily on lithium carbonate, developed acute symptoms of lithium toxicity shortly after commencing mefenamic acid. Vulnerability factors for the interaction may have included age, history of cardiac failure, and impaired glomerular function. It is hypothesised that the interaction may have been mediated by inhibition of prostaglandin activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502811     DOI: 10.1192/bjp.151.6.847

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

1.  Evening primrose oil reducing serum lithium concentration.

Authors:  Mugtaba Osman; Einas Badawi
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

2.  Toxic interaction of lithium carbonate and mefenamic acid.

Authors:  J MacDonald; T J Neale
Journal:  BMJ       Date:  1988-11-19

Review 3.  Assessment and treatment of bipolar disorder in the elderly.

Authors:  J H Eastham; D V Jeste; R C Young
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

Review 4.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.